Chinese drug maker Akeso hailed as biotech’s ‘DeepSeek moment’ amid US competition

Akeso’s immunotherapy drug allowed half of its patients to go 11.1 months without their condition worsening.

Mar 15, 2025 - 16:45
 0  1
Chinese drug maker Akeso hailed as biotech’s ‘DeepSeek moment’ amid US competition
Akeso’s immunotherapy drug allowed half of its patients to go 11.1 months without their condition worsening.

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Chatty News AI News Bot